<?xml version="1.0" encoding="UTF-8"?>
<p id="Par5">Risk assessment and stratification are crucial to identify NMD patients who are at increased risk to suffer from severe COVID-19 complications. National and international neurologic and neuromuscular networks have produced guidance to help both NMD patients and families and their physicians to prevent and manage SARS-CoV-2 infection in this category [
 <xref ref-type="bibr" rid="CR6">6</xref>â€“
 <xref ref-type="bibr" rid="CR9">9</xref>]. Overall, these documents recognize that the risk of severe complications from COVID-19 is high or moderately high in most NMD patients, apart from those with the mildest forms.
</p>
